Skip to content

Author

Soo-Chin Lee

We have 2 of 274 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

To stop or not to stop? International physician survey on HER2 targeted therapy for metastatic breast cancer patients in remission

Introduction HER2-targeted therapy (HER2-TT) has improved outcomes in HER2+ metastatic breast cancer (MBC) with increasing numbers of long-term survivors in complete response (CR). Little is known about discontinuing maintenance HER2-TT in these patients. Methods An online survey of physicians was conducted via the Bre...

Han-Yi Lee, W. Ong, V. Tjan-Heijnen et al. · 0 citations
Review Open access Aug 2026

Double heterozygous germline pathogenic variants in patients referred to a tertiary cancer genetics clinic in Singapore

The findings emphasise the need for tailored genetic evaluation and further research to guide evidence-based management for this complex patient population and the need for tailored genetic evaluation for this complex patient population of cancer patients.

R. Wong, Yi-Ong Pei, S. Ow et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.